Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
ClearPoint Neuro, Inc.ClearPoint Neuro Reports 41% Revenue Growth, Improved Gross Profit in Q3 2024
Axogen, Inc.Axogen Reports 17.9% Revenue Growth, Improved Financial Performance in Q3 2024
HANCOCK WHITNEY CORPHancock Whitney Reports Mixed Q3 Results with Increased Profitability and Challenges in Loan Growth and Credit Quality
Dutch Bros Inc.Dutch Bros Reports 27.9% Revenue Growth and 62.1% Net Income Increase in Q3 2024
OneStream, Inc.OneStream Reports 21% Revenue Growth, Net Loss Widens in Q3 2024
A.K.A. BRANDS HOLDING CORP.a.k.a. Brands Holding Corp. Reports Improved Financial Performance in Q3 2024
Evoke Pharma IncEvoke Pharma Reports Improved Financials, Increased Cash and Cash Equivalents, and Growing Net Product Sales
MID PENN BANCORP INCMid Penn Bancorp Reports 33% Increase in Net Income, 4.5% Growth in Total Assets for Q3 2024
Oscar Health, Inc.Oscar Health Reports 70% Revenue Growth, Net Income Recovery in Q3 2024
Lucid Group, Inc.Lucid Group Reports Decline in Revenue and Increased Net Losses in Q3 2024
FLOTEK INDUSTRIES INC/CN/Flotek Industries Reports Mixed Q3 Results, Net Income Up 92% Despite Revenue Decline
Poseida Therapeutics, Inc.Poseida Therapeutics Reports Significant Revenue Growth, Improved Operational Efficiency in Q3 2024
Rallybio CorpRallybio Reports Reduced Losses, Increased Revenue in Q3 2024
AVITA Medical, Inc.AVITA Medical Reports 43.2% Revenue Growth, Widened Net Loss in Q3 2024
Nerdy Inc.Nerdy Inc. Reports Mixed Q3 and 9-Month Financial Results, Revenue Down 7% in Q3 but Up 3% for 9 Months
RCM TECHNOLOGIES, INC.RCM Technologies Reports Mixed Financial Results, Revenue Growth, and Strategic Developments
Target Group Inc.Target Group Inc. Reports Decline in Revenue and Assets, Raises Concerns About Going Concern
MACERICH COMacerich Reports Improved Revenue and Profitability in Q3 2024, Net Income Turnaround
Doximity, Inc.Doximity Reports 20% Revenue Growth, Strong Operational Performance in Latest Quarter
StepStone Group Inc.StepStone Group Reports 42% Revenue Growth, Net Income Decline in Latest Quarter
Skye Bioscience, Inc.Skye Bioscience Reports Significant Financial Developments, Commences Phase 2 Clinical Trial for Lead Drug Candidate
MCKESSON CORPMckesson Reports 21% Revenue Growth, Decline in Profitability Amid Increased Expenses and Restructuring Efforts
MANNKIND CORPMannKind Corporation Reports 37% Revenue Growth, Net Income Turnaround in Q3 2024
BRUKER CORPBruker Corporation Reports 16.4% Revenue Growth, Decline in Profitability in Q3 2024
Axonics, Inc.Axonics Reports 24.8% Revenue Growth, Narrowed Net Loss in Q3 2024